Qube Research & Technologies LTD Bausch Health Companies Inc. Transaction History

Qube Research & Technologies LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$7.77 - $10.61 $47,031 - $64,222	6,053 New	6,053 $64,000
Q1 2023 May 15, 2023	BUY	$6.28 - $9.85 $2.61 Million - $4.1 Million	416,291 New	416,291 $3.37 Million
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $1.98 Million - $6.64 Million	-280,862 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$21.6 - $27.79 $6.07 Million - $7.81 Million	280,862 New	280,862 $6.42 Million
Q4 2021 Feb 01, 2022	SELL	$23.0 - $29.01 $1.84 Million - $2.32 Million	-80,126 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $1.98 Million - $2.38 Million	-79,120 Reduced 49.68%	80,126 $2.23 Million
Q2 2021 Aug 13, 2021	SELL	$27.43 - $32.7 $422,888 - $504,135	-15,417 Reduced 8.83%	159,246 $4.67 Million
Q1 2021 May 14, 2021	BUY	$21.37 - $34.38 $2.9 Million - $4.66 Million	135,539 Added 346.43%	174,663 $5.54 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $598,988 - $826,298	39,124 New	39,124 $814,000
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $1.14 Million - $1.75 Million	-85,302 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$12.98 - $30.25 $1.11 Million - $2.58 Million	85,302 New	85,302 $1.32 Million

255

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.7B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.